Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Doxepin hydrochloride [antipruritic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin hydrochloride 50 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin hydrochloride 10mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin hydrochloride 10mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin hydrochloride 25mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin hydrochloride 50mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely doxepin hydrochloride 150 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin hydrochloride 75mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely doxepin hydrochloride 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin (as doxepin hydrochloride) 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely doxepin (as doxepin hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin (as doxepin hydrochloride) 75 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Doxepin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Doxepin (as doxepin hydrochloride) 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin (as doxepin hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Doxepin (as doxepin hydrochloride) 75 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin hydrochloride 150 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin hydrochloride 150 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin hydrochloride 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin hydrochloride 100 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin hydrochloride 150 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin hydrochloride 100 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Doxepin (as doxepin hydrochloride) 25 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin (as doxepin hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Doxepin (as doxepin hydrochloride) 75 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Doxepin hydrochloride 50 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Doxepin hydrochloride 50 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely doxepin (as doxepin hydrochloride) 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |
Doxepin (as doxepin hydrochloride) 150 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Doxepin hydrochloride |
Inferred relationship |
Some |
1 |